AutoimmunityResults in Tumor Rejection But Not Activation of Low Avidity CTL Specific for a Self

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8.

  1997cited by this paper
• Tolerance to p53 by A2.1-restricted Cytotoxic T Lymphocytes

  1997cited by this paper
• Tolerance is overcome in beef insulin‐transgenic mice by activation of low‐affinity autoreactive T cells

  1996cited by this paper
• Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

  1996cited by this paper
• Influence of antigen dose and costimulation on the primary response of CD8+ T cells in vitro

  1996cited by this paper
• Granulocyte‐macrophage‐colony‐stimulating factor enhances immune responses to melanoma‐associated peptides in vivo

  1996cited by this paper
• T cell responses are governed by avidity and co‐stimulatory thresholds

  1996cited by this paper
• Therapy of murine tumors with p53 wild-type and mutant sequence peptide- based vaccines

  1996cited by this paper
• T cell tolerance and activation to a transgene‐encoded tumor antigen

  1996cited by this paper
• Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide.

  1996cited by this paper
• p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.

  1996cited by this paper
• Duration of TCR stimulation determines costimulatory requirement of T cells.

  1996cited by this paper
• MHC class I-restricted CTL responses to exogenous antigens.

  1996cited by this paper
• CD8(+) T cell-mediated spontaneous diabetes in neonatal mice.

  1996cited by this paper
• New perspectives of C1328-137-mediated T cell costimulation

  1995cited by this paper
• Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

  1995cited by this paper
• Induction of anti-self-immunity to cure cancer.

  1995cited by this paper
• Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3

  1995cited by this paper
• A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

  1995cited by this paper
• Fibroblasts as efficient antigen-presenting cells in lymphoid organs.

  1995cited by this paper
• Targeting p53 as a general tumor antigen.

  1995cited by this paper
• Melanocyte lineage-specific antigen gp100 is recognized by melanoma- derived tumor-infiltrating lymphocytes

  1994cited by this paper
• Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

  1994cited by this paper
• Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

  1994cited by this paper
• Dose‐dependent T cell tolerance to an immunodominant self peptide

  1994cited by this paper
• T-cell apoptosis detected in situ during positive and negative selection in the thymus

  1994cited by this paper
• Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice

  1994cited by this paper
• A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

  1994cited by this paper
• In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein.

  1994cited by this paper
• Absence of B7-dependent responses in CD28-deficient mice.

  1994cited by this paper
• Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

  1994cited by this paper
• Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels.

  1994cited by this paper
• How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model.

  1994cited by this paper
• Tumor antigens recognized by T lymphocytes.

  1994cited by this paper
• Differential T cell costimulatory requirements in CD28-deficient mice.

  1993cited by this paper
• The antitumor immune response as a problem of self-nonself discrimination: Implications for immunotherapy

  1993cited by this paper
• The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

  1993cited by this paper
• Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene.

  1993cited by this paper
• Dominance and crypticity of T cell antigenic determinants.

  1993cited by this paper
• Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity.

  1993cited by this paper
• Hen egg-white lysozyme-specific T cells elicited in hen egg-white lysozyme-transgenic mice retain an imprint of self-tolerance.

  1993cited by this paper
• Comparison of the T cell receptors on insulin-specific hybridomas from insulin transgenic and nontransgenic mice. Loss of a subpopulation of self-reactive clones.

  1992cited by this paper
• Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection.

  1992cited by this paper
• Peripheral T cell tolerance.

  1992cited by this paper
• Peripheral tolerance to an islet cell‐specific hemagglutinin transgene affects both CD4+ and CD8+ T cells

  1992cited by this paper
• Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.

  1991cited by this paper
• Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

  1991cited by this paper
• Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells.

  1991cited by this paper
• Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

  1991cited by this paper
• A peripheral mechanism preserves self-tolerance to a secreted protein in transgenic mice.

  1990cited by this paper
• Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes

  1988cited by this paper
• T-cell receptor Vβ use predicts reactivity and tolerance to Mlsa- encoded antigens

  1988cited by this paper
• T cell tolerance by clonal elimination in the thymus.

  1987cited by this paper
• p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors

  1985cited by this paper
• Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes

  1984cited by this paper
• Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

  1976cited by this paper
• A murine renal cell carcinoma.

  1973cited by this paper

• No citing papers are available for this paper.